1. Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib

   • Donald M. Black
   • Darren Bentley
   • Therese Heinonen

   Review Article Open access 05 May 2018 Pages: 1359 - 1367

   

2. Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir

   • Polina German
   • Anita Mathias
   • Brian P. Kearney

   Review Article 11 April 2018 Pages: 1369 - 1383

3. Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics

   • Ranjeet Prasad Dash
   • R. Jayachandra Babu
   • Nuggehally R. Srinivas

   Review Article 23 April 2018 Pages: 1385 - 1398

   

4. Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens

   • Thomas Tängdén
   • Pier Giorgio Cojutti
   • Federico Pea

   Original Research Article 15 March 2018 Pages: 1399 - 1405

   

5. Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Hepatitis C Virus-Infected Cirrhotic and Non-cirrhotic Patients: Analyses Across Nine Phase III Studies

   • Sathej Gopalakrishnan
   • Sven Mensing
   • Jiuhong Zha

   Original Research Article 07 March 2018 Pages: 1407 - 1419

   

6. A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women

   • Stein Schalkwijk
   • Rob ter Heine
   • David M. Burger

   Original Research Article Open access 08 March 2018 Pages: 1421 - 1433

   

7. Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients

   • Pieter J. Colin
   • Stijn Jonckheere
   • Michel M. R. F. Struys

   Original Research Article Open access 06 March 2018 Pages: 1435 - 1447

   

8. Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment

   • Erik Mogalian
   • Diana M. Brainard
   • Anita Mathias

   Original Research Article 08 March 2018 Pages: 1449 - 1457

   

9. A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators

   • Ida Robertsen
   • Jean Debord
   • Jean-Baptiste Woillard

   Original Research Article 20 March 2018 Pages: 1459 - 1469

   

10. Comment on “Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials”

    • Joseph F. Standing
    • Brian J. Anderson
    • Amin Rostami-Hodjegan

    Letter to the Editor 20 July 2018 Pages: 1471 - 1472

    

11. Authors’ Reply to Standing et al.: “Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials”

    • Sven C. van Dijkman
    • Nico C. B. de Jager
    • Oscar Della Pasqua

    Letter to the Editor 20 July 2018 Pages: 1473 - 1475